Showing results (11-20 of 287) with videos related to
Sort By:
Pageof 29
Psychopharmacology|January 1, 1993
Effects of acute doses of oxiracetam in the scopolamine model of human amnesiaL Preda, M Alberoni, S Bressi, et al.Journal of Gerontology|July 1, 1989
Neuron-binding antibodies in Alzheimer's disease and Down's syndromeM Franceschi, M Comola, R Nemni, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1991
ACTH and cortisol secretion in patients with Alzheimer's diseaseM Franceschi, L Airaghi, C Gramigna, et al.Archives of Neurology|December 1, 1989
Cortical pathophysiology and clinical neurologic abnormalities in acute cerebral ischemia. A serial study with single photon emission computed tomographyM Rango, L Candelise, D Perani, et al.Acta Neurologica Scandinavica|April 1, 1993
SPET imaging of cerebral perfusion in patients with non-refractory temporal lobe epilepsyM Franceschi, C Messa, L Ferini-Strambi, et al.Dementia (Basel, Switzerland)|March 1, 1996
Pattern visual evoked potential mapping in Alzheimer's disease: correlations with visuospatial impairmentV Martinelli, T Locatelli, G Comi, et al.Dementia (Basel, Switzerland)|January 1, 1995
Correlations between cognitive impairment, middle cerebral artery flow velocity and cortical glucose metabolism in the early phase of Alzheimer's diseaseM Franceschi, M Alberoni, S Bressi, et al.Clinical Neuroscience (New York, N.Y.)|January 1, 1997
Autoimmunity and diabetic neuropathyN Canal, R NemniClinical Pharmacology and Therapeutics|August 1, 1996
Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease. Eptastigmine Study GroupN Canal, B P ImbimboJournal of Neurology|January 1, 1975
The metabolism of cyclic-3'-5'-adenosine monophosphate (cAMP) in diseased muscleN Canal, L Frattola, S SmirnePageof 29